# Reviva Pharmaceuticals Holdings, Inc.: Form 8-K, filed Mar 31, 2025

- Company: [Reviva Pharmaceuticals Holdings, Inc.](/companies/rvph.md) (CIK 1742927)
- Form: 8-K
- Filed: 2025-03-31
- Accepted by EDGAR: Mar 31, 2025, 16:12 ET
- Period: 2025-03-31
- Accession: 0001437749-25-010191
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1742927/000143774925010191/rvph20250325_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1742927/000143774925010191/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1742927/000143774925010191/rvph20250325_8k.htm

Filed Mar 31, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-010191. Last ingested by Listed: Oct 29, 2026, 16:33 ET. No prices; not investment advice.